BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ming Y, Xin G, Ji B, Ji C, Wei Z, Zhang B, Zhang J, Yu K, Zhang X, Li S, Li Y, Xing Z, Niu H, Huang W. Entecavir as a P2X7R antagonist ameliorates platelet activation and thrombus formation. J Pharmacol Sci 2020;144:43-51. [PMID: 32653340 DOI: 10.1016/j.jphs.2020.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferrari D, Rubini M, Burns JS. The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2. Front Immunol 2022;13:904419. [DOI: 10.3389/fimmu.2022.904419] [Reference Citation Analysis]
2 Rawish E, Langer HF. Platelets and the Role of P2X Receptors in Nociception, Pain, Neuronal Toxicity and Thromboinflammation. Int J Mol Sci 2022;23:6585. [PMID: 35743029 DOI: 10.3390/ijms23126585] [Reference Citation Analysis]
3 Marchese P, Lombardi M, Mantione ME, Baccellieri D, Ferrara D, Chiesa R, Alfieri O, Foglieni C. Confocal Blood Flow Videomicroscopy of Thrombus Formation over Human Arteries and Local Targeting of P2X7. Int J Mol Sci 2021;22:4066. [PMID: 33920051 DOI: 10.3390/ijms22084066] [Reference Citation Analysis]
4 Shokoples BG, Paradis P, Schiffrin EL. P2X7 Receptors: An Untapped Target for the Management of Cardiovascular Disease. Arterioscler Thromb Vasc Biol 2021;41:186-99. [PMID: 32998520 DOI: 10.1161/ATVBAHA.120.315116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]